Director Willie M. Reed receives 1,936 Zoetis (ZTS) restricted stock units

Q: When do Willie M. Reed’s new Zoetis (ZTS) RSUs vest?

The newly granted RSUs are scheduled to vest and be settled in Zoetis common stock on the first anniversary of the grant date, February 18, 2026 . Vesting remains subject to Reed’s continued service and certain specified earlier-vesting events.

Q: What does each Zoetis (ZTS) restricted stock unit granted to Willie M. Reed represent?

Each RSU granted to Willie M. Reed represents a contingent right to receive one share of Zoetis Inc. common stock. This means he will receive actual shares only upon vesting and settlement according to the award terms.

Q: Under which plan were Willie M. Reed’s Zoetis (ZTS) RSUs granted?

The reported RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan . The award also includes dividend-equivalent units automatically issued on the RSUs, further aligning compensation with Zoetis share performance.

Q: Are Willie M. Reed’s Zoetis (ZTS) RSUs an open-market stock purchase?

No. The filing describes the transaction as a grant or award acquisition of RSUs at $0.00 per unit. This reflects equity-based compensation, not an open-market buy or sell of Zoetis common stock by the director.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Reed Willie M reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. director Willie M. Reed reported an equity award of 1,936 restricted stock units (RSUs) granted on February 18, 2026 at a price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Zoetis common stock and was granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, including related dividend-equivalent units. According to the terms, these RSUs will vest and be settled in Zoetis common shares on the first anniversary of the grant date, February 18, 2026, subject to Reed’s continued service and certain earlier-vesting events.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Reed Willie M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	1,936	$0.00	--
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 1,936 shares (Direct)

Footnotes (1)

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Form 4 Insider Transactions: What Each Field Means →

02/19/2026 - 08:52 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Willie M

(Last)

(First)

(Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY

07054

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit⁽¹⁾	⁽²⁾	02/18/2026		A		1,936		⁽³⁾	⁽⁴⁾	Common Stock	1,936	$0	1,936	D
Restricted Stock Unit⁽¹⁾	⁽²⁾							⁽⁵⁾	⁽⁴⁾	Common Stock	1,619.3325		1,619.3325	D

Explanation of Responses:

1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

2. Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

4. Not applicable.

5. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Zoetis (ZTS) director Willie M. Reed report?

Zoetis director Willie M. Reed reported receiving an award of 1,936 restricted stock units (RSUs). These RSUs were granted at $0.00 per unit under the company’s equity and incentive plan, representing additional potential future Zoetis common shares.

When do Willie M. Reed’s new Zoetis (ZTS) RSUs vest?

The newly granted RSUs are scheduled to vest and be settled in Zoetis common stock on the first anniversary of the grant date, February 18, 2026. Vesting remains subject to Reed’s continued service and certain specified earlier-vesting events.

What does each Zoetis (ZTS) restricted stock unit granted to Willie M. Reed represent?

Each RSU granted to Willie M. Reed represents a contingent right to receive one share of Zoetis Inc. common stock. This means he will receive actual shares only upon vesting and settlement according to the award terms.

Under which plan were Willie M. Reed’s Zoetis (ZTS) RSUs granted?

The reported RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. The award also includes dividend-equivalent units automatically issued on the RSUs, further aligning compensation with Zoetis share performance.

Are Willie M. Reed’s Zoetis (ZTS) RSUs an open-market stock purchase?

No. The filing describes the transaction as a grant or award acquisition of RSUs at $0.00 per unit. This reflects equity-based compensation, not an open-market buy or sell of Zoetis common stock by the director.